Titan Medical Statistics

Total Valuation

Titan Medical has a market cap or net worth of CAD 5.13 million. The enterprise value is 1.28 million.

Market Cap	5.13M
Enterprise Value	1.28M

Important Dates

The last earnings date was Monday, November 11, 2024.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

Titan Medical has 4.56 million shares outstanding. The number of shares has increased by 1.43% in one year.

Current Share Class	n/a
Shares Outstanding	4.56M
Shares Change (YoY)	+1.43%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.11%
Owned by Institutions (%)	3.95%
Float	113.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.31
PB Ratio	1.37
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.17
EV / Sales	2.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.73, with a Debt / Equity ratio of 0.40.

Current Ratio	3.73
Quick Ratio	3.42
Debt / Equity	0.40
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-19.03

Financial Efficiency

Return on equity (ROE) is -106.83% and return on invested capital (ROIC) is -26.26%.

Return on Equity (ROE)	-106.83%
Return on Assets (ROA)	-20.00%
Return on Invested Capital (ROIC)	-26.26%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	153,973
Profits Per Employee	-1.92M
Employee Count	4
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.29% in the last 52 weeks. The beta is 1.98, so Titan Medical's price volatility has been higher than the market average.

Beta (5Y)	1.98
52-Week Price Change	-64.29%
50-Day Moving Average	1.30
200-Day Moving Average	1.65
Relative Strength Index (RSI)	48.30
Average Volume (20 Days)	2,008

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Titan Medical had revenue of CAD 615,893 and -7.67 million in losses. Loss per share was -1.84.

Revenue	615,893
Gross Profit	615,893
Operating Income	-3.80M
Pretax Income	-7.63M
Net Income	-7.67M
EBITDA	-3.51M
EBIT	-3.80M
Loss Per Share	-1.84

Full Income Statement

Balance Sheet

The company has 5.36 million in cash and 1.50 million in debt, giving a net cash position of 3.86 million or 0.85 per share.

Cash & Cash Equivalents	5.36M
Total Debt	1.50M
Net Cash	3.86M
Net Cash Per Share	0.85
Equity (Book Value)	3.74M
Book Value Per Share	0.82
Working Capital	4.45M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-8.57M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-617.56%
Pretax Margin	-1,239.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Titan Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.43%
Shareholder Yield	-1.43%
Earnings Yield	n/a
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 19, 2018. It was a reverse split with a ratio of 0.0333333.

Last Split Date	Jun 19, 2018
Split Type	Reverse
Split Ratio	0.0333333

Scores

Titan Medical has an Altman Z-Score of -88.44. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-88.44
Piotroski F-Score	n/a